Director/PDMR Shareholding

RNS Number : 9399S
GlaxoSmithKline PLC
22 March 2016
 

GlaxoSmithKline plc

 

Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons

 

 

In accordance with DTR 3.1.4R (1) (a) I give details of changes in the interests of Roger Connor, a Person Discharging Managerial Responsibility, in the Ordinary Shares of GlaxoSmithKline plc (the "Company") following:

 

1.   the exercise of a nil cost option over 3,680 Ordinary Shares on 22 March 2016, granted on 28 February 2013, which vested on 28 February 2016 under the GlaxoSmithKline Deferred Annual Bonus Plan;

 

2.   the sale of 3,680 Ordinary shares on 22 March 2016 at a price of £13.78 per share; and

 

3.   the sale of 19,320 Ordinary Shares on 22 March 2016 at a price of £13.76 per share.

 

 

The Company and Mr Connor were advised of these transactions on 22 March 2016.

 

 

V A Whyte

Company Secretary

 

22 March 2016

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSELLFLQXFFBBX

Companies

GSK (GSK)
UK 100

Latest directors dealings